SCHEMBL13092003

SCHEMBL13092003

CC(=O)[C@@H](NC(=O)[C@@H](NC(=O)c1cnccn1)C1CCCCC1)C(C)(C)C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 1/20 0.54
CTSB P07858 4/20 0.52
ELANE P08246 2/20 0.52
CTSL P07711 2/20 0.52
CTSV O60911 1/20 0.52
PLG P00747 1/20 0.52
CMA1 P23946 1/20 0.52
CTSS P25774 1/20 0.52
CTSK P43235 1/20 0.52
CELA1 Q9UNI1 1/20 0.52
LONP1 P36776 3/20 0.46
GAA P10253 1/20 0.45
MAPT P10636 1/20 0.45
PSMB11 A5LHX3 1/20 0.43
PSMA7 O14818 1/20 0.43
PSMB1 P20618 1/20 0.43
PSMA1 P25786 1/20 0.43
PSMA2 P25787 1/20 0.43
PSMA3 P25788 1/20 0.43
PSMA4 P25789 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12011280 1.00 ABCG2 (0.54) ABCG2CTSBELANECTSLCTSV
SCHEMBL12331437 1.00 ABCG2 (0.54) ABCG2CTSBELANECTSLCTSV
SCHEMBL1013600 0.92 ABCG2 (0.54) ABCG2CTSBELANECTSLCTSV
SCHEMBL1013602 0.92 ABCG2 (0.54) ABCG2CTSBELANECTSLCTSV
SCHEMBL2408343 0.92 ABCG2 (0.54) ABCG2CTSBELANECTSLCTSV
SCHEMBL464244 0.92 ABCG2 (0.54) ABCG2CTSBELANECTSLCTSV
SCHEMBL3213475 0.92 ABCG2 (0.54) ABCG2CTSBELANECTSLCTSV
SCHEMBL2410890 0.92 ABCG2 (0.54) ABCG2CTSBELANECTSLCTSV
SCHEMBL12404543 0.91 ABCG2 (0.53) ABCG2CTSBELANECTSLCTSV
SCHEMBL15764295 0.91 ABCG2 (0.53) ABCG2CTSBELANECTSLCTSV

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013135870-A1 PROCESS FOR THE SYNTHESIS OF TELAPREVIR, OR PHARMACEUTICALLY ACCEPTABLE SALTS OR SOLVATES AS WELL AS INTERMEDIATE PRODUCTS THEREOF SANDOZ AG (CH) 2013-09-19 WO disclosed
US-7820671-B2 Hepatitis C antiviral agents including telaprevir (VX 950); higher tolerance, reduced side effects; azaheterocyclic amido ketone derivatives VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-10-26 US disclosed